Fumagalli, Giorgio Giulio
 Distribuzione geografica
Continente #
NA - Nord America 4.308
AS - Asia 3.672
EU - Europa 2.347
SA - Sud America 731
Continente sconosciuto - Info sul continente non disponibili 455
AF - Africa 95
OC - Oceania 21
Totale 11.629
Nazione #
US - Stati Uniti d'America 4.128
SG - Singapore 1.572
IT - Italia 971
CN - Cina 699
BR - Brasile 617
VN - Vietnam 522
RU - Federazione Russa 244
GB - Regno Unito 220
KR - Corea 172
DE - Germania 166
FR - Francia 159
LV - Lettonia 141
HK - Hong Kong 134
BD - Bangladesh 122
ID - Indonesia 118
IN - India 103
CA - Canada 98
FI - Finlandia 91
NL - Olanda 88
AT - Austria 76
IQ - Iraq 50
MX - Messico 48
AR - Argentina 35
JP - Giappone 35
PL - Polonia 27
ZA - Sudafrica 27
PK - Pakistan 26
EC - Ecuador 23
IE - Irlanda 23
AU - Australia 20
ES - Italia 19
TR - Turchia 17
GR - Grecia 15
HU - Ungheria 15
SA - Arabia Saudita 15
UA - Ucraina 13
BE - Belgio 12
CL - Cile 12
JO - Giordania 12
MA - Marocco 12
PT - Portogallo 11
SE - Svezia 11
VE - Venezuela 11
JM - Giamaica 10
KE - Kenya 9
PH - Filippine 9
TN - Tunisia 9
CH - Svizzera 8
EG - Egitto 8
PE - Perù 8
PY - Paraguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
CR - Costa Rica 7
DZ - Algeria 7
ET - Etiopia 6
RS - Serbia 6
UY - Uruguay 6
HN - Honduras 5
IR - Iran 5
LB - Libano 5
OM - Oman 5
BG - Bulgaria 4
GE - Georgia 4
PA - Panama 4
SN - Senegal 4
AL - Albania 3
CI - Costa d'Avorio 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
MY - Malesia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GA - Gabon 2
GH - Ghana 2
IL - Israele 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
GM - Gambi 1
Totale 11.160
Città #
Singapore 987
Ashburn 711
San Jose 664
Columbus 385
Trento 352
Council Bluffs 340
Dallas 276
Santa Clara 271
Seoul 168
Ho Chi Minh City 158
Riga 141
Moscow 137
Hanoi 133
Hong Kong 129
Los Angeles 127
Hefei 125
Lauterbourg 114
Milan 104
Jakarta 94
New York 91
Nuremberg 78
The Dalles 75
Chicago 64
Beijing 61
London 61
Washington 60
São Paulo 59
Buffalo 56
Redondo Beach 54
Orem 46
Rome 46
Da Nang 43
Munich 42
Lappeenranta 40
Boardman 38
Helsinki 33
Salt Lake City 32
Frankfurt am Main 30
Tokyo 30
Amsterdam 29
Miano 26
Vienna 25
Haiphong 24
Montreal 22
Rio de Janeiro 21
Warsaw 21
Guangzhou 20
Dublin 19
Brooklyn 18
Chennai 18
Baghdad 17
Paris 17
Belo Horizonte 16
Curitiba 16
Shanghai 16
Tampa 16
Denver 15
Mexico City 15
Toronto 15
Mumbai 14
North Bergen 14
Turku 14
Atlanta 13
Budapest 13
Phoenix 12
Bassano del Grappa 11
Florence 11
Houston 11
Johannesburg 11
Biên Hòa 10
Brasília 10
Charlotte 10
Elk Grove Village 10
Manchester 10
Ottawa 10
Quito 10
Amman 9
Campinas 9
Erbil 9
New Delhi 9
Philadelphia 9
Seattle 9
Tempe 9
Daiano 8
Dhaka 8
Imperia 8
Islington 8
Porto Alegre 8
Tashkent 8
Athens 7
Bologna 7
Boston 7
Brisbane 7
Bến Tre 7
Cairo 7
Dongguan 7
Guarulhos 7
Kilburn 7
Miami 7
Nairobi 7
Totale 7.223
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 274
The search for a link between autism spectrum disorder and neurodegenerative dementia 243
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 160
Utility of visual rating scales in primary progressive aphasia 153
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills 140
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 132
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 130
Mental State Recognition Deficits Linked to Brain Changes in Parkinson's Disease Without Dementia 128
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 124
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 122
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 115
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 111
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 108
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 107
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study 106
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 101
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 101
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint 100
MRI visual rating scales in the diagnosis of dementia: Evaluation in 184 post-mortem confirmed cases 100
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 99
Clinical Heterogeneity in Alzheimer’s Disease: A Possible New Amnesic Phenotype 99
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study 98
Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease 93
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 93
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 93
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 92
Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia 91
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status 90
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 90
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 90
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: A GENFI study 90
Predictor model for mild cognitive impairment in Parkinson’s disease using visual rating scales 89
The Italian fund for Alzheimer's and other dementias: strategies and objectives to face the dementia challenge 89
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage 89
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study 88
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers 88
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 87
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 87
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 87
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 86
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 86
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 86
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 86
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 83
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia 83
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 83
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 82
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 82
The potential of neurovascular modulation with tDCS: an exploratory analysis in older adults with hypertension. 82
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 81
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 81
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 81
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia 80
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 80
Teaching NeuroImage: Crowned Dens Syndrome: An Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis 79
The role of sex and education in the clinical manifestation and progression of Posterior Cortical Atrophy. 79
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters 78
Differential early subcortical involvement in genetic FTD within the GENFI cohort 77
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 77
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 77
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 77
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 77
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 76
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 76
Education modulates brain maintenance in presymptomatic frontotemporal dementia 75
A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort 75
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 74
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 74
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 74
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 73
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 73
Altered plasma protein profiles in genetic FTD - a GENFI study 73
Disease-related cortical thinning in presymptomatic granulin mutation carriers 73
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 72
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 71
Crossing Borders between Frontotemporal Dementia and Psychiatric Disorders: An Updated Overview 71
Unravelling the Association between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+? 71
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration 71
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 70
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 70
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia 70
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 70
Caregiver Tele-Assistance for Reduction of Emotional Distress during the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience 70
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 69
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes 69
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 69
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 69
Diogenes syndrome in dementia: a case report 69
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 68
Behavioral and neurophysiological effects of transcranial direct current stimulation (tDCS) in fronto-temporal dementia 67
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia 67
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 67
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 66
Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian cohort of Geriatric Outputs: A Retrospective Cross-sectional Study 65
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 65
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 64
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 64
Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling 64
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study 63
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 63
Totale 8.890
Categoria #
all - tutte 61.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 568
Totale 61.693


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023528 0 0 0 50 255 99 26 26 25 5 10 32
2023/2024977 5 12 77 30 78 215 159 91 10 87 68 145
2024/20252.778 62 31 140 473 118 375 67 79 412 342 307 372
2025/20266.814 236 152 749 1.000 870 446 1.220 183 523 727 288 420
2026/2027532 158 374 0 0 0 0 0 0 0 0 0 0
Totale 11.629